A multicenter study on the prevalence of diabetic neuropathy in Italy

Diabetes Care

Volumn 20, Issue 5, 1997, Pages 836-843

  Fedele, Domenico ^a,h   Comi, Giancarlo ^b   Coscelli, Carlo ^c   Cucinotta, Domenico ^d   Feldman, Eva L ^e   Ghirlanda, Giovanni ^f   Greene, Douglas A ^e   Negrin, Paolo ^a   Santeusanio, Fausto ^g  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Parma Hospital   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF PERUGIA   (Italy)

^h Centro Antidiabetico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; NEUROLOGICAL COMPLICATION; PREVALENCE; SCORING SYSTEM;

EID: 0030991905     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.5.836     Document Type: Article

References (33)

1. Committee Health Care Issues American Neurological Association: Does improved control of glycemia prevent or ameliorate diabetic neuropathy? (Abstract). Ann Neurol 19:288, 1986
2. Pirart J: Diabetes mellitus and its degenerative complications; a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188, 1978
3. The DCCT Research Group: Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481, 1988
4. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH: A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150-154, 1993
5. Comi G, Negrin P, Troni W, Fedele D, Cardone C, Marchettini P, Carta Q, Canal N, Crepaldi G, Pozza G, Vitelli A, Ripamonti G, Perkins M: Quantitative sensory testing, cardiovascular autonomic tests and nerve conduction studies in diabetic neuropathy. In Diabetic Neuropathy. Ward J, Goto Y, Eds. Chichester, Wiley, 1990, p. 351-359
6. Veglio M, Sivieri R: Prevalence of neuropathy in IDDM patients in Piemonte Italy. Diabetes Care 16:456-461, 1993
7. Cardone C, Fedele D, Bax G, Paiusco P, Cavarzeran F, Meneghini F, Grigoletto F: Prevalence of neuropathic abnormalities in a diabetic population in Italy. In Controversies of Etiology and Treatment of Diabetic Neuropathy. Ward JD, Goto Y, Eds. New York, 14th International Diabetes Federation Congress, 1991
8. Brand PW: The diabetic foot. In Diabetes Mellitus: Medical Examination. Ellenberg M, Rifkin H, Eds. New York, Medical Examination Publishing, 1983, p. 829-849
9. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes Care 15:1902-1925, 1992
10. The DCCT Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
11. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230:101-108, 1991
12. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289, 1994
13. Bax G, Fagherazzi C, Piarulli F, Nicolucci A, Fedele D: Reproducibility of Michigan Neuropathy Screening Instrument. Diabetes Care 19:904-905, 1996
14. Kimura J: Principles of nerve conduction studies. In Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. Kimura J, Ed. Philadelphia, Davis, 1989, p. 83-104
15. American Diabetes Association: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes 37:1000-1004, 1988
16. Dyck PJ: Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11:21-32, 1988
17. Dyck PJ, Kratz KM, Lehman KA: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807, 1991
18. Dyck PJ, Karnes JL, O'Bnen PC: The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 42:1164-1170, 1992
19. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J: Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 235:463-471, 1994
20. Moss SE, Klein R, Klein BEK: The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 152:610-616, 1992
21. Humphrey LL, Palumbo PJ, Butters MA, Hallett JW Jr, Chu CP, O'Fallon WM, Ballard DJ: The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community. Arch Intern Med 154:885-892, 1994
22. Ahroni JH, Boyko EJ, Davignon DR, Pecoraro RE: The health and functional status of veterans with diabetes. Diabetes Care 17:318-321, 1994
23. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pack JM, Wilson DM, O'Brien PC, Melton LS III: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
24. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard TJ: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study Diabetes 38:1456-1461, 1989
25. Dyck PJ, Karnes JL, Daube J: Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108:861-880, 1985
26. Garancini MP, Calori G, Ruotolo G, Manara E, Izzo A, Ebili E, Bozzetti AM, Boari L, Lazzeri P, Gallus G: Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study Diabetologia 38:306-313, 1995
27. Boulton AJM: Clinical presentation and management of diabetic neuropathy and foot ulceration (Symposium). Diabet Med 8:S52-S57, 1991
28. Larsen K, Christiansen JS, Ebskov B: Prevention and treatment of ulcerations of the foot in unilaterally amputated diabetic patients. Acta Orthop Scand 53:481-485, 1982
29. Greene DA, Feldman EL, Stevens MJ: Neuropathy in the diabetic foot: new concepts in etiology and treatment. In The Diabetic Foot. 5th ed. Levin M, O'Neal L, Eds. St. Louis, MO, Mosby, 1993, p. 135-148
30. Hollingshead TS: Pathophysiology and treatment of diabetic foot ulcer. Clin Podiatr Med Surg 8:843-855, 1991
31. Joseph R, Cavuoto JW: The latest theories and treatment for diabetic foot complications. Clin Podiatr Med Surg 8:249-272, 1991
32. Apelqvist J, Larsson J, Agardh CD: The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complications 4:21-25, 1990
33. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993